High Cholesterol (Hypercholesterolemia) Protocol

CardiovascularStrong Evidence

supplements

Primary

Supporting

Grade A

180

Studies

Primary Stack

Core supplements with strongest evidence

Plant Sterols/StanolsA

2-3g daily with meals

Structurally similar to cholesterol, they compete for intestinal absorption, reducing dietary and biliary cholesterol uptake

40 studies4,000 participants

Supporting Studies (2)

PMID: 19939984 - Plant sterols/stanols for cholesterol: meta-analysis (2009)PMID: 25411277 - Efficacy of plant sterols on LDL-C: systematic review (2014)

Soluble Fiber (Beta-glucan/Psyllium)A

3g beta-glucan or 10g psyllium daily

Binds bile acids, increasing hepatic LDL receptor expression to clear more cholesterol from blood

↓Blood glucose↑Insulin

35 studies2,500 participants

Supporting Studies (2)

PMID: 21631511 - Soluble fiber and LDL cholesterol: meta-analysis (2011)PMID: 26269239 - Oat beta-glucan for cholesterol reduction (2015)

Supporting Stack

Additional supplements for enhanced results

Red Yeast RiceA

1200-2400mg daily (standardized to 3-10mg monacolin K)

Contains monacolin K (natural lovastatin) that inhibits HMG-CoA reductase, reducing cholesterol synthesis

20 studies2,000 participants

Supporting Studies (1)

PMID: 20479151 - Red yeast rice for hypercholesterolemia: systematic review (2010)

BerberineA

500mg 2-3x daily with meals

Inhibits PCSK9 to increase LDL receptor expression and activates AMPK to reduce cholesterol synthesis

↓Blood glucose↓Total cholesterol↓Triglycerides↑Glycemic Control↓HbA1c

20 studies1,800 participants

Supporting Studies (1)

PMID: 22529926 - Berberine for cholesterol reduction: meta-analysis (2012)

Omega-3 Fatty AcidsB

2-4g EPA/DHA daily (for triglycerides)

Primarily lowers triglycerides; modest effect on raising HDL; little direct LDL-lowering effect

AdiponectinApolipoprotein A↓Triglycerides↓Total cholesterol↑High-density lipoprotein (HDL)

40 studies3,500 participants

Supporting Studies (1)

PMID: 27159202 - Omega-3s and lipid profiles: meta-analysis (2016)

Niacin (Vitamin B3)B

1-2g extended-release daily (with physician monitoring)

Raises HDL cholesterol significantly while lowering LDL and triglycerides

Glycemic Control↑Hepatic Glucose Production↑High-density lipoprotein (HDL)↓Low-density lipoprotein (LDL)↓Triglycerides

25 studies3,000 participants

Supporting Studies (1)

PMID: 19749196 - Niacin for lipid management: systematic review (2009)

How This Protocol Works

Simple Explanation

High cholesterol, particularly elevated LDL ('bad cholesterol'), is a major risk factor for heart disease and stroke. Cholesterol comes from two sources: dietary intake and liver production. This protocol addresses both pathways while also supporting HDL ('good cholesterol').

•Plant Sterols/Stanols are one of the most effective natural cholesterol-lowering supplements. These plant compounds are structurally similar to cholesterol, so they compete with cholesterol for absorption in your intestines. Taking 2-3g daily can reduce LDL by 6-15%. They're often found fortified in margarine spreads, yogurt drinks, and standalone supplements.

•Soluble Fiber (Beta-glucan/Psyllium) works by binding bile acids in your intestine. Your liver then has to use more cholesterol to make new bile acids, reducing the cholesterol circulating in your blood. The FDA allows health claims for oat beta-glucan—just 3g daily (about 1.5 cups of oatmeal) can lower LDL by 5-10%. Psyllium works similarly.

•Red Yeast Rice contains monacolin K, which is chemically identical to the prescription statin lovastatin. It can lower LDL by 15-25%. However, because it works like a statin, it has similar precautions—potential for muscle problems and liver effects. Quality varies greatly between products, and some may contain contaminants.

•Berberine is a remarkable compound that lowers LDL by 20-25%—comparable to a low-dose statin—but through a different mechanism. It inhibits PCSK9, which increases the number of LDL receptors on liver cells, helping clear more cholesterol from your blood. It also lowers triglycerides and blood sugar.

•Omega-3 Fatty Acids primarily lower triglycerides (by 15-30%) rather than LDL. However, they're important for overall cardiovascular health and can raise HDL modestly. Higher doses (2-4g) are needed for significant lipid effects.

•Niacin (Vitamin B3) is the most effective supplement for raising HDL—increases of 15-35% are common. It also lowers LDL and triglycerides. However, it causes uncomfortable flushing in most people, and extended-release forms are better tolerated.

Expected timeline: LDL reductions from fiber and plant sterols appear within 4-6 weeks. Berberine and red yeast rice effects visible in 4-8 weeks. Retest your lipid panel after 8-12 weeks of supplementation.

Clinical Perspective

Hypercholesterolemia is defined as total cholesterol >200 mg/dL or LDL-C >130 mg/dL. Elevated LDL-C drives atherosclerosis through subendothelial retention, oxidation, and macrophage foam cell formation. LDL-C is the primary treatment target; non-HDL-C and apoB are secondary markers. This protocol targets cholesterol absorption, hepatic synthesis, and clearance.

•Plant Sterols/Stanols (A-grade): Structural analogs of cholesterol (sitosterol, campesterol, stigmasterol). Displace cholesterol from intestinal micelles, reducing absorption by ~50%. Meta-analysis of 124 studies: 2g/day reduces LDL-C by 8-10% (PMID: 19939984). Effects additive to statins. FDA-approved health claim. Distributed across meals optimizes efficacy. May reduce fat-soluble vitamin absorption—consider vitamin D supplementation.

•Soluble Fiber (A-grade): Beta-glucan (oats, barley) and psyllium form viscous gel binding bile acids, interrupting enterohepatic circulation. Liver compensates by upregulating LDL receptor expression. Meta-analysis: 3g/day beta-glucan reduces LDL-C by 5-7% (PMID: 26269239). FDA-approved health claim for oat fiber. Also improves glycemic control. Increase intake gradually to minimize GI symptoms.

•Red Yeast Rice (A-grade): Fermented rice (Monascus purpureus) containing monacolin K (lovastatin). Inhibits HMG-CoA reductase, reducing hepatic cholesterol synthesis. Systematic review: reduces LDL-C by 15-25% (PMID: 20479151). CAUTION: Same mechanism as statins—contraindicated with statin therapy; similar risk of myopathy, hepatotoxicity. Products vary widely in monacolin content (0-10mg). Some contaminated with citrinin (nephrotoxin). Requires same monitoring as statins.

•Berberine (A-grade): Alkaloid that inhibits PCSK9 secretion, increasing hepatic LDL receptor expression (same pathway as evolocumab). Also activates AMPK, reducing SREBP-mediated lipogenesis. Meta-analysis: reduces LDL-C by 20-25% (25 mg/dL), TG by 35 mg/dL (PMID: 22529926). Comparable efficacy to ezetimibe. May inhibit CYP enzymes—check interactions. GI side effects common initially.

•Omega-3 Fatty Acids (B-grade): EPA/DHA reduce hepatic VLDL synthesis. Primary effect is TG reduction (15-30%). Minimal direct LDL-lowering; may slightly raise LDL with mixed EPA/DHA products (EPA-only doesn't). Important for cardiovascular protection beyond lipid effects. Meta-analysis supports TG-lowering at doses ≥2g (PMID: 27159202).

•Niacin (B-grade): Inhibits adipocyte lipolysis (GPR109A), reducing hepatic VLDL production. Also inhibits DGAT2. Raises HDL 15-35% by reducing HDL catabolism. Systematic review confirms lipid benefits (PMID: 19749196). However, AIM-HIGH and HPS2-THRIVE trials showed no incremental CV benefit when added to statins. Flushing is dose-limiting—extended-release preferred; aspirin pre-dose helps.

Biomarker targets: LDL-C (<100 mg/dL, <70 for high risk), non-HDL-C (<130), apoB (<90), TC/HDL ratio (<4), TG (<150), HDL-C (>40 M/>50 F), Lp(a) (measure once for risk stratification).

Protocol notes: Statins remain first-line for high ASCVD risk. Supplements appropriate for statin intolerance, mild hypercholesterolemia, or adjunctive therapy. Plant sterols + fiber: safe, effective combination for 15-20% LDL reduction. Red yeast rice: treat as low-dose statin with appropriate monitoring. Berberine: effective alternative for statin-intolerant. Lifestyle foundational: saturated fat <7% calories, trans fat elimination, Mediterranean diet pattern, 150 min/week exercise. Recheck lipids 8-12 weeks after intervention.

View All Protocols